vs
DIGI INTERNATIONAL INC（DGII）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是DIGI INTERNATIONAL INC的1.3倍（$168.4M vs $130.7M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 25.1%），过去两年DIGI INTERNATIONAL INC的营收复合增速更高（11.5% vs 10.6%）
Digi International Inc.是总部位于美国明尼苏达州霍普金斯的工业物联网（IIoT）科技企业，成立于1985年。上世纪90年代初，该公司以生产多线路串行数据卡闻名，可支持兼容机运行多线路公告板系统（BBS）。90年代末互联网兴起后，公司逐步转向网络接入设备与工业监测领域布局。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
DGII vs ESPR — 直观对比
营收规模更大
ESPR
是对方的1.3倍
$130.7M
营收增速更快
ESPR
高出118.6%
25.1%
两年增速更快
DGII
近两年复合增速
10.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $130.7M | $168.4M |
| 净利润 | $11.3M | — |
| 毛利率 | 64.0% | — |
| 营业利润率 | 13.1% | 50.6% |
| 净利率 | 8.6% | — |
| 营收同比 | 25.1% | 143.7% |
| 净利润同比 | 7.7% | — |
| 每股收益（稀释后） | $0.29 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGIIESPR
| Q1 26 | $130.7M | — | ||
| Q4 25 | $122.5M | $168.4M | ||
| Q3 25 | $114.3M | $87.3M | ||
| Q2 25 | $107.5M | $82.4M | ||
| Q1 25 | $104.5M | $65.0M | ||
| Q4 24 | $103.9M | $69.1M | ||
| Q3 24 | $105.1M | $51.6M | ||
| Q2 24 | $105.2M | $73.8M |
净利润DGIIESPR
| Q1 26 | $11.3M | — | ||
| Q4 25 | $11.7M | — | ||
| Q3 25 | $10.0M | $-31.3M | ||
| Q2 25 | $10.2M | $-12.7M | ||
| Q1 25 | $10.5M | $-40.5M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $11.9M | $-29.5M | ||
| Q2 24 | $9.7M | $-61.9M |
毛利率DGIIESPR
| Q1 26 | 64.0% | — | ||
| Q4 25 | 62.4% | — | ||
| Q3 25 | 63.9% | — | ||
| Q2 25 | 63.5% | — | ||
| Q1 25 | 62.1% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 59.2% | — |
营业利润率DGIIESPR
| Q1 26 | 13.1% | — | ||
| Q4 25 | 13.3% | 50.6% | ||
| Q3 25 | 12.5% | -11.4% | ||
| Q2 25 | 13.9% | 8.6% | ||
| Q1 25 | 13.1% | -34.0% | ||
| Q4 24 | 12.9% | -6.4% | ||
| Q3 24 | 14.2% | -31.0% | ||
| Q2 24 | 12.3% | 3.5% |
净利率DGIIESPR
| Q1 26 | 8.6% | — | ||
| Q4 25 | 9.6% | — | ||
| Q3 25 | 8.7% | -35.9% | ||
| Q2 25 | 9.5% | -15.4% | ||
| Q1 25 | 10.0% | -62.2% | ||
| Q4 24 | 9.7% | — | ||
| Q3 24 | 11.3% | -57.2% | ||
| Q2 24 | 9.2% | -83.9% |
每股收益（稀释后）DGIIESPR
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.31 | $0.32 | ||
| Q3 25 | $0.26 | $-0.16 | ||
| Q2 25 | $0.27 | $-0.06 | ||
| Q1 25 | $0.28 | $-0.21 | ||
| Q4 24 | $0.27 | $-0.14 | ||
| Q3 24 | $0.32 | $-0.15 | ||
| Q2 24 | $0.26 | $-0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.7M | $167.9M |
| 总债务越低越好 | $143.0M | — |
| 股东权益账面价值 | $666.0M | $-302.0M |
| 总资产 | $974.2M | $465.9M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资DGIIESPR
| Q1 26 | $31.7M | — | ||
| Q4 25 | $30.9M | $167.9M | ||
| Q3 25 | $21.9M | $92.4M | ||
| Q2 25 | $20.1M | $86.1M | ||
| Q1 25 | $26.3M | $114.6M | ||
| Q4 24 | $25.9M | $144.8M | ||
| Q3 24 | $27.5M | $144.7M | ||
| Q2 24 | $28.3M | $189.3M |
总债务DGIIESPR
| Q1 26 | $143.0M | — | ||
| Q4 25 | $135.0M | — | ||
| Q3 25 | $159.2M | — | ||
| Q2 25 | $40.1M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $123.2M | — | ||
| Q2 24 | $151.6M | — |
股东权益DGIIESPR
| Q1 26 | $666.0M | — | ||
| Q4 25 | $649.2M | $-302.0M | ||
| Q3 25 | $636.1M | $-451.4M | ||
| Q2 25 | $621.5M | $-433.5M | ||
| Q1 25 | $605.2M | $-426.2M | ||
| Q4 24 | $590.7M | $-388.7M | ||
| Q3 24 | $581.0M | $-370.2M | ||
| Q2 24 | $563.1M | $-344.2M |
总资产DGIIESPR
| Q1 26 | $974.2M | — | ||
| Q4 25 | $918.4M | $465.9M | ||
| Q3 25 | $922.6M | $364.0M | ||
| Q2 25 | $770.3M | $347.1M | ||
| Q1 25 | $781.0M | $324.0M | ||
| Q4 24 | $796.1M | $343.8M | ||
| Q3 24 | $815.1M | $314.1M | ||
| Q2 24 | $820.4M | $352.3M |
负债/权益比DGIIESPR
| Q1 26 | 0.21× | — | ||
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.25× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $77.1M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 6.82× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DGIIESPR
| Q1 26 | $77.1M | — | ||
| Q4 25 | $35.6M | $45.2M | ||
| Q3 25 | $28.0M | $-4.3M | ||
| Q2 25 | $24.0M | $-31.4M | ||
| Q1 25 | $26.3M | $-22.6M | ||
| Q4 24 | $29.7M | $-35.0M | ||
| Q3 24 | $26.4M | $-35.3M | ||
| Q2 24 | $24.9M | $-7.2M |
自由现金流DGIIESPR
| Q1 26 | — | — | ||
| Q4 25 | $35.2M | — | ||
| Q3 25 | $27.5M | — | ||
| Q2 25 | $22.9M | — | ||
| Q1 25 | $25.7M | — | ||
| Q4 24 | $29.1M | — | ||
| Q3 24 | $25.5M | $-35.5M | ||
| Q2 24 | $24.5M | $-7.3M |
自由现金流率DGIIESPR
| Q1 26 | — | — | ||
| Q4 25 | 28.7% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 21.3% | — | ||
| Q1 25 | 24.6% | — | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 24.3% | -68.7% | ||
| Q2 24 | 23.2% | -9.9% |
资本支出强度DGIIESPR
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 0.0% | ||
| Q3 25 | 0.4% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.5% | 0.0% | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 0.5% | 0.1% |
现金转化率DGIIESPR
| Q1 26 | 6.82× | — | ||
| Q4 25 | 3.04× | — | ||
| Q3 25 | 2.81× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 2.95× | — | ||
| Q3 24 | 2.23× | — | ||
| Q2 24 | 2.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DGII
暂无分部数据
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
